DE69626624D1 - Medikamente gegen trhombocytopenie - Google Patents

Medikamente gegen trhombocytopenie

Info

Publication number
DE69626624D1
DE69626624D1 DE69626624T DE69626624T DE69626624D1 DE 69626624 D1 DE69626624 D1 DE 69626624D1 DE 69626624 T DE69626624 T DE 69626624T DE 69626624 T DE69626624 T DE 69626624T DE 69626624 D1 DE69626624 D1 DE 69626624D1
Authority
DE
Germany
Prior art keywords
group
chr1r2
chr3r4
chr5r6
2chr3r4
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626624T
Other languages
English (en)
Other versions
DE69626624T2 (de
Inventor
Masayuki Saitoh
Yasuo Kitajima
Norio Iwasawa
Kenju Miura
Munetada Haruyama
Junko Hashino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69626624D1 publication Critical patent/DE69626624D1/de
Publication of DE69626624T2 publication Critical patent/DE69626624T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
DE69626624T 1995-10-17 1996-10-17 Medikamente gegen trhombocytopenie Expired - Fee Related DE69626624T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26864495 1995-10-17
PCT/JP1996/003008 WO1997014704A1 (fr) 1995-10-17 1996-10-17 Medicament contre la thrombopenie

Publications (2)

Publication Number Publication Date
DE69626624D1 true DE69626624D1 (de) 2003-04-17
DE69626624T2 DE69626624T2 (de) 2003-11-27

Family

ID=17461419

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626624T Expired - Fee Related DE69626624T2 (de) 1995-10-17 1996-10-17 Medikamente gegen trhombocytopenie

Country Status (9)

Country Link
US (1) US6040335A (de)
EP (1) EP0798304B1 (de)
KR (1) KR980700316A (de)
AT (1) ATE234315T1 (de)
AU (1) AU702751B2 (de)
CA (1) CA2207656A1 (de)
DE (1) DE69626624T2 (de)
ES (1) ES2195016T3 (de)
WO (1) WO1997014704A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2416304T3 (es) * 2002-01-18 2013-07-31 Astellas Pharma Inc. Derivado de 2-acilaminotiazol o sal del mismo
US7851503B2 (en) 2002-08-14 2010-12-14 Nissan Chemical Industries, Ltd. Thrombopoetin receptor activator and process for producing the same
AU2006313491B2 (en) * 2005-11-08 2011-01-06 Astellas Pharma Inc. Compositions and methods for treating thrombocytopenia
CA2660283C (en) * 2006-08-08 2014-11-18 Akarx, Inc. 2-acylaminothiazole compositions and methods for increasing blood platlelet levels in humans

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235913A (en) * 1977-06-07 1980-11-25 Pfizer Inc. 9-Hydroxyhexahydrodibeno[b,d]pyrans, 1-substituted-9-hydroxyhexahydrodibenzo]b,d]pyrans
US4725602A (en) * 1984-02-06 1988-02-16 Mcneilab, Inc. Acetylene amines and their use as vasodilators and antihypertensives
JPH02186A (ja) * 1987-05-07 1990-01-05 Sumitomo Chem Co Ltd 新規化合物およびそれを有効成分とする農工業用殺菌剤
JP2865302B2 (ja) * 1988-02-13 1999-03-08 サントリー株式会社 ２―ピラノン誘導体及びその製造法並びにそれを含む抗菌剤
AU649116B2 (en) * 1991-03-27 1994-05-12 Sankyo Company Limited New compounds, named the "Leustroducins", their preparation and their therapeutic uses
JP3034646B2 (ja) * 1991-06-20 2000-04-17 三共株式会社 Ｇ−ｃｓｆおよびｇｍ−ｃｓｆ誘導剤
JPH05213758A (ja) * 1992-02-06 1993-08-24 Sankyo Co Ltd 血小板増多剤
JPH05221867A (ja) * 1992-02-17 1993-08-31 Sankyo Co Ltd Ｉｌ−６誘導剤
DE69410159T2 (de) * 1993-04-23 1999-01-28 Sankyo Co Neue Verbindung, Leustroducsin H, ihre Herstellung und therapeutische Verwendung
JPH0841087A (ja) * 1994-08-03 1996-02-13 Sankyo Co Ltd Ｎ−アシルロイストロダクシン類

Also Published As

Publication number Publication date
EP0798304A1 (de) 1997-10-01
WO1997014704A1 (fr) 1997-04-24
KR980700316A (ko) 1998-03-30
EP0798304A4 (de) 1999-02-10
DE69626624T2 (de) 2003-11-27
US6040335A (en) 2000-03-21
EP0798304B1 (de) 2003-03-12
CA2207656A1 (en) 1997-04-24
ATE234315T1 (de) 2003-03-15
AU702751B2 (en) 1999-03-04
ES2195016T3 (es) 2003-12-01
AU7332996A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
CY1117132T1 (el) Παραγωγο θειαζολιου
DE69528485D1 (de) Biphenylderivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE60311821D1 (de) Dibenzylaminverbindung und deren medizinische verwendung
DE68906183D1 (de) 2'-desoxy-5-fluoruridinderivate.
DK0565377T3 (da) Terapeutiske midler til behandling af Parkinsons sygdom
DE60142934D1 (de) Pharmazeutische dopamin-glykokonjugat-zusammensetzungen und verfahren zu deren herstellung
ES2095855T3 (es) Derivados de tetrahidrobencimidazol.
ATE34976T1 (de) Arylcyclobutylalkylamine und ihre verwendung als antidepressive arzneimittel.
ATE402151T1 (de) 2-(arylphenyl)amino-imidazolin-derivate
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
DE69626624D1 (de) Medikamente gegen trhombocytopenie
DE69319900D1 (de) N,n'-disubstituierte amidderivate
DE69129790T2 (de) 5-Amino-5,6,7,8-Tetrahydrochinoline und verwandte Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE69624459T2 (de) Kondensierte indan-derivate und ihre salze
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
DE69303352T2 (de) Verfahren zur Herstellung 5-Pyrazolomerkaptan-Derivate und dessen zwischenprodukte
ATE268769T1 (de) Pyrimidinderivate mit antitumor-wirkung

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee